Photo: World Economic Forum, CC BY 3.0, via Wikimedia Commons²⁸

Michel Vounatsos

Pharmaceutical executive.¹

Born 1961.¹

Companies

Zai Lab LimitedBoard member Jan 13, 2023 to now⁹
Revvity Inc.Board member Mar 2, 2020 to now¹⁰
BiogenChief executive officer Jan 6, 2017 to Nov 21, 2022¹¹
BiogenBoard member Feb 17, 2017 to Feb 23, 2022¹²
BiogenEVP & Chief Commercial Officer Apr 22, 2016 to May 4, 2016¹³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Biogen BIIB67,261 shares¹⁴$16.2M at $241.24Feb 18, 2022
Revvity Inc. RVTY13,977 shares¹⁵$2.1M at $152.28May 7, 2026
Zai Lab Limited ZLAB72,787 shares¹⁶$1.7M at $24.01Jun 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 17, 2026Granted 22,371 shares of Zai Lab Limited¹⁶
May 7, 2026Granted 1,265 shares of Revvity Inc.¹⁵
May 7, 2026Granted 1,015 shares of Revvity Inc.¹⁵
Jun 18, 2025Granted 10,831 shares of Zai Lab Limited¹⁷
Apr 30, 2025Granted 1,338 shares of Revvity Inc.¹⁸
Apr 30, 2025Granted 1,074 shares of Revvity Inc.¹⁸
Jun 18, 2024Granted 21,253 shares of Zai Lab Limited¹⁹
May 1, 2024Granted 1,218 shares of Revvity Inc.²⁰
May 1, 2024Granted 977 shares of Revvity Inc.²⁰
May 15, 2023Granted 955 shares of Revvity Inc.²¹
May 15, 2023Granted 783 shares of Revvity Inc.²¹
Mar 3, 2023Granted 18,332 shares of Zai Lab Limited²²
May 6, 2022Granted 744 shares of Revvity Inc.²³
May 6, 2022Granted 610 shares of Revvity Inc.²³
Feb 18, 2022Shares withheld for tax 2,746 shares at $209.79 of Biogen¹⁴
Feb 18, 2022Exercised options 6,191 shares of Biogen¹⁴
Feb 12, 2022Shares withheld for tax 4,699 shares at $214.59 of Biogen²⁴
Feb 12, 2022Shares withheld for tax 1,950 shares at $214.59 of Biogen²⁴
Feb 12, 2022Exercised options 4,395 shares of Biogen²⁴
Feb 12, 2022Shares withheld for tax 1,917 shares at $214.59 of Biogen²⁴
Feb 12, 2022Exercised options 4,321 shares of Biogen²⁴
Jan 19, 2022Granted 10,594 shares of Biogen²⁵
May 7, 2021Granted 709 shares of Revvity Inc.²⁶
May 7, 2021Granted 604 shares of Revvity Inc.²⁶
May 8, 2020Granted 1,081 shares of Revvity Inc.²⁷

Early life and education

1988Bordeaux Segalen University Q2946878; medicine²
1990HEC Paris Master of Business Administration^{2 3}

Career

Occupation: business executive.⁷

Since 2017Chief executive, Biogen⁶
Until 2016Worked at Merck & Co.^{4 5}
Since 2016Worked at Biogen^{4 5}

Personal life

CitizenshipFrance⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataMichel Vounatsos on Wikidata
2
WikidataMichel Vounatsos: education, on Wikidata
3
Wikidataeducation, as reported
4
WikidataMichel Vounatsos: Worked at Merck & Co., on Wikidata
5
WikidataWorked at Merck & Co., as reported
6
WikidataMichel Vounatsos: Chief executive, Biogen, on Wikidata
7
WikidataMichel Vounatsos: occupation, on Wikidata
8
WikidataMichel Vounatsos: citizenship, on Wikidata
9
SEC EDGARZai Lab Limited, Board member
10
SEC EDGARRevvity Inc., Board member
11
Wikidata and SEC EDGARBiogen, Chief executive officer
12
SEC EDGARBiogen, Board member
13
SEC EDGARBiogen, EVP & Chief Commercial Officer
14
SEC EDGARBiogen shares after the filing of Feb 18, 2022
15
SEC EDGARRevvity Inc. shares after the filing of May 7, 2026
16
SEC EDGARZai Lab Limited shares after the filing of Jun 17, 2026
17
SEC EDGARForm 4 filed Jun 23, 2025
18
SEC EDGARForm 4 filed May 1, 2025
19
SEC EDGARForm 4 filed Jun 20, 2024
20
SEC EDGARForm 4 filed May 2, 2024
21
SEC EDGARForm 4 filed May 17, 2023
22
SEC EDGARForm 4 filed Mar 7, 2023
23
SEC EDGARForm 4 filed May 9, 2022
24
SEC EDGARForm 4 filed Feb 15, 2022
25
SEC EDGARForm 4 filed Jan 21, 2022
26
SEC EDGARForm 4 filed May 10, 2021
27
SEC EDGARForm 4 filed May 12, 2020
28
Wikimedia CommonsMichel Vounatsos photo by World Economic Forum, CC BY 3.0